Skip to content
18 November · 06:30 UTCFollow AstraZeneca by emailFollow

AZN · story · 18 November

Strand Life Sciences and AstraZeneca Pharma India sign letter of intent

AstraZeneca · 10 headlines from 9 outlets, on 18 November 2026.

The story

+3.6positive
Headlines10
Outlets9
Days118 November

Many outlets report that Strand Life Sciences, a Reliance unit, and AstraZeneca Pharma India signed a letter of intent.

The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.

How each outlet covered it · 9 outlets

Every outlet, by impact on the tone

Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone.

Source: MarketFrame news analysis

Every outlet, by impact on the tone. Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone. Source: MarketFrame news analysis
outletAverage tone
Business Upturn3.3
Upstox5.8
LinkedIn3.3
BusinessLine3.3
Equitypandit3.3
scanx.trade3.3
Sahi3.3
The Financial Express3.3
CNBC TV183.3
OutletHeadlinesAverage tone
Business Upturn2+3.3
Upstox1+5.8
LinkedIn1+3.3
BusinessLine1+3.3
Equitypandit1+3.3
scanx.trade1+3.3
Sahi1+3.3
The Financial Express1+3.3
CNBC TV181+3.3

One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.

Day by day · 1 day, strongest headlines first

Wednesday 18 November 202610 headlines · Many outlets report that Strand Life Sciences, a Reliance unit, and AstraZeneca Pharma India signed a letter of intent.+3.6
ToneWhat the article reported, and why it scored that waySource
+5.8Indian shares gain after partnership announcement.Upstox (opens the article) ↗
+3.3Indian arm signs letter of intent with Reliance unit.LinkedIn (opens the article) ↗
+3.3Indian unit agrees to explore healthcare collaboration.BusinessLine (opens the article) ↗
+3.3Indian arm signs preliminary collaboration deal.Equitypandit (opens the article) ↗
+3.3Indian unit signs collaboration letter of intent.scanx.trade (opens the article) ↗
+3.3Indian arm partners on healthcare collaboration.Sahi (opens the article) ↗
+3.3Indian arm teams up with Reliance-owned genomics firm.The Financial Express (opens the article) ↗
+3.3Indian arm signs letter of intent with Reliance unit.CNBC TV18 (opens the article) ↗
2 more headlines that day
ToneWhat the article reported, and why it scored that waySource
+3.3Indian subsidiary explores healthcare collaboration with a partner.Business Upturn (opens the article) ↗
+3.3Indian unit signs preliminary letter of intent for collaboration.Business Upturn (opens the article) ↗

Follow by email

A short, free morning email on how the news treated AstraZeneca: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.

How it works. Every morning an AI model reads the UK business news about each FTSE 100 company and scores how good or bad it is for the company, from −10 to +10. Pages update by about 07:45 UK time.

Not investment advice. MarketFrame rates the tone of news coverage. It is general information, not a recommendation to buy or sell anything. The scores are not share-price data or forecasts: a good score doesn't mean a share will rise, and a bad one doesn't mean it will fall.

Data to 06:30 UTC, 18 November · 867 headlines · 94 companiesMade by Adapt Progress Evolve Limited, a UK company · Privacy · Terms · Who we are · RSS · API · llms.txt